Yeastern Biotech Co., Ltd. is a Taiwanese private company located in Taipei that manufactures molecular biological reagents, health foods and cosmeceutical products.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.

BioVex is a biotechnology company focused on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. Their cancer program, OncoVEXGM-CSF, is a oncolytic vaccine or cancer destroying virus technology that works by replicating and spreading within solid tumors, causing the death of cancer cells while leaving surrounding healthy cells unharmed. The attenuated virus has also been constructed to induce a powerful systemic anti tumor immune response. OncoVEXGM-CSF has now been tested in >110 patients in a broad range of solid tumors including melanoma, head & neck cancer, breast cancer and pancreatic cancer. Both the direct cell killing and systemic immune mediated mechanisms of action of OncoVEX have been clearly validated in the clinic; OncoVEX routinely destroys tumors it is directly injected into and has led to overall disease responses in multiple patients in Phase II testing. Tumors resolved through OncoVEX treatment have not been known to recur.

Discovers and develops novel therapeutics for inflammatory disorders

OncoSec Medical is an advanced-stage biomedical company that focuses on the development of novel therapeutic oncology products. The company's core technology is an untapped delivery system, that applies short electric impulses to a tumor, causing transient pores to open in the cellular membrane, allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS electroporation. Using OMS electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells embedded among predominantly healthy tissue.

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.

Shanghai Academy of Agricultural Science is a private company headquartered in Shanghai, China, that provides agricultural research services.

Part of AbbVie, Inc., AbbVie Biotherapeutics, Inc. is an American company located in North Chicago, IL, that develops oncology drugs.

Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400 people in Austria, Scotland and the United States.

Part of British American Tobacco plc, Kentucky BioProcessing LLC is a company headquartered in Owensboro, KY, that produces plant-made proteins. On January 02, 2014 Reynolds American, Inc., part of British American Tobacco plc since July 2017, acquired Kentucky BioProcessing LLC from Owensboro Health, Inc.\nThe company says this about itself: KBP is located in Owensboro, Ky., where it began operations in 2006. In January 2014, KBP was acquired by and became an independently operated, wholly-owned subsidiary of Reynolds American Inc. (RAI), a British American Tobacco Group Company. KBP continues to house its large, multilevel indoor plant-growth space, as well as its research and production laboratories, clean rooms and manufacturing operations in Owensboro. KBP made headlines in 2014 for its role developing the Ebola treatment, ZMapp�� in collaboration with California-based company Mapp BioPharmaceutical and the U.S. Biomedical Advanced Research and Development Authority (BARDA).

Large Scale Biology Corp. is a biotechnology company, which develops and manufactures recombinant biologics. Its products includes vaccines, complex proteins and follow-on off-patent therapeutics. It is located in Vacaville, CA.

In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. At Takeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer. They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Qinling Health Pharmaceutical Industry Technology Co., Ltd., established on 2017-12-04, The scope of business includes the development of medical research experiments;Planting and sales of Chinese herbal medicines and wormwood;Protection and Utilization of Original and Endangered Chinese Medicinal Materials in Qinling Mountains;Traditional Chinese Medicine Health Service;Production and sales of traditional Chinese medicine health and hygiene products;Traditional Chinese medicine preparation technical service;Production and sales of medical cosmetics and daily care products;Production and sales of Ganoderma lucidum immunomodulatory protein preparations and compound products;Production and sales of plant essential oils and products;Healthy culture,technology,Method research promotion and health care services;Health and Wellness Cultural Tourism Consulting and Services;Health care industry development and management;Technology development in the field of medical and health technology,technology transfer,technical consulting,Technical Services;research and development,Production,Sell ​​various ai products,Health and wellness products,Edible produce,Health products,Class I medical device,Electronic and electrical products,Cultural Tourism Souvenirs,artwork;Pre-packaged food,Wholesale sales of bulk food;healthy drink,Tea,Production and sales of tea products;Production and sales of traditional Chinese medicine processing machinery and equipment;Development and sales of application software;International exhibition consulting services and exchange activities;e-commerce;Health Data Management;Technical testing;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)